On November 26, 2025, at the first China Pharmaceutical Listed Company Value Management Summit Awards Ceremony, TUL was listed on the "2025 China Pharmaceutical Listed Company ESG Competitiveness TOP20 (Mid Cap Stock)" list for its outstanding performance in ESG transparency, ESG governance, and important issue management evaluation, and was awarded the "2025 China Pharmaceutical Listed Company Most Competitive Top 20" certificate.